Discontinuation report GD-AZITHROMYCIN

Last updated on 2018-10-19 History
Report ID 62358
Drug Identification Number 02274566
Brand name GD-AZITHROMYCIN
Common or Proper name AZITHROMYCIN
Company Name GENMED A DIVISION OF PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) AZITHROMYCIN
Strength(s) 100MG
Dosage form(s) POWDER FOR SUSPENSION
Route of administration ORAL
Packaging size 1 Bottle (300MG/15ML)
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for discontinuation Business reasons
Anticipated discontinuation date 2019-11-30
Actual discontinuation date
Remaining supply date 2019-11-30
Discontinuation status To be discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-800-387-4974 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2018-09-25 English Compare
v2 2018-09-25 French Compare
v3 2018-10-19 English Compare
v4 2018-10-19 French Compare

Showing 1 to 4 of 4